For Multi-Program Companies
Portfolio Assessment
Program-by-program evaluation at study level for companies deciding where to concentrate resources. Scientific rationale, competitive positioning, preclinical feasibility, and commercial potential assessed across your full pipeline, with a clear prioritization recommendation and board-ready narrative.
What's Included
A structured assessment that gives you clarity across every program in your portfolio.
- Detailed assessment per program: scientific rationale, competitive landscape, preclinical feasibility, and commercial potential
- Next-study plan for each program
- Head-to-head comparison across programs
- Prioritization recommendation with rationale
- Portfolio budget and timeline
- Board narrative
Who This Is For
Built for teams navigating multi-program portfolio decisions.
Companies with 2+ programs deciding where to focus
Teams preparing for board-level portfolio reviews
Companies needing to justify resource allocation to investors
Related Services
Once you've prioritized, these engagements take your lead program forward.
Ready to Prioritize Your Portfolio?
Book a Strategy Call. We'll discuss your programs and recommend the right scope for your assessment.
Book a Strategy Call30-minute call · No obligation · Confidential
info@bridgelinetranslational.com · bridgelinetranslational.com